Cargando…
Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain
The bioactive lipid lysophosphatidylcholine (LPC), a major phospholipid component of oxidized low-density lipoprotein (Ox-LDL), originates from the cleavage of phosphatidylcholine by phospholipase A2 (PLA2) and is catabolized to other substances by different enzymatic pathways. LPC exerts pleiotropi...
Autores principales: | Ren, Jinxuan, Lin, Jiaqi, Yu, Lina, Yan, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368269/ https://www.ncbi.nlm.nih.gov/pubmed/35955410 http://dx.doi.org/10.3390/ijms23158274 |
Ejemplares similares
-
Targeting lipid droplet lysophosphatidylcholine for cisplatin chemotherapy
por: Chen, Lumin, et al.
Publicado: (2020) -
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
por: Law, Shi-Hui, et al.
Publicado: (2019) -
Myristoyl lysophosphatidylcholine is a biomarker and potential therapeutic target for community-acquired pneumonia
por: Nan, Wengang, et al.
Publicado: (2022) -
The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities
por: Lin, Jiaqi, et al.
Publicado: (2021) -
Effects of Lysophosphatidylcholine on Jejuna Morphology and Its Potential Mechanism
por: Li, Xiaofeng, et al.
Publicado: (2022)